Article Information
vol. 4 no. 4
Published By
Online ISSN
History
- Received May 29, 2018
- Accepted October 26, 2018
- Published online December 21, 2018.
Copyright & Usage
Copyright ©ERS 2018 This article is open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0.
Author Information
- Paraskevi Katsaounou⇑1,
- Mikaela Odemyr2,
- Otto Spranger3,
- Michael E. Hyland4,
- Claus Kroegel5,
- Lorena Garcia Conde6,
- Robin Gore7,
- Francesco Menzella8,
- Christian Domingo Ribas9,
- Mario Morais-Almeida10,
- Matthias Gasser11 and
- Ismail Kasujee6
- 1First ICU Evaggelismos Hospital, National and Kapodistrian University of Athens, Athens, Greece
- 2European Federation of Allergy and Airways Diseases Patients’ Associations, Brussels, Belgium
- 3Global Allergy and Asthma Patient Platform, Vienna, Austria
- 4School of Psychology, University of Plymouth, Plymouth, UK
- 5Dept of Pneumology and Allergy/Immunology, Medical University Hospital Jena, Jena, Germany
- 6Novartis Pharma AG, Basel, Switzerland
- 7Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK
- 8Specialist Medicine Dept, Pneumology Unit, Arcispedale Santa Maria Nuova, Reggio Emilia, Italy
- 9Pulmonary Service, Corporació Sanitària Parc Taulí (Sabadell), Dept of Medicine, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain
- 10Allergy Center, CUF Descobertas Hospital, Lisbon, Portugal
- 11GfK Switzerland AG, Basel, Switzerland
- Paraskevi Katsaounou, 20 Evergeti Giavasi str, 15341, Athens, Greece. E-mail: paraskevikatsaounou{at}gmail.com
Funding
Novartis